Amyris Has Big Growth Plans (Again). It Will Likely Fail to Meet Them (Again)
1 min readAmyris Has Big Growth Plans (Again). It Will Likely Fail to Meet Them (Again)
The synthetic-biology pioneer has wooed investors with grandiose plans for 2019 and beyond. A look at past promises suggests failure is a more likely outcome.